|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/137 | |
| A61K 31/365 | |||
| A61K 31/4035 | |||
| A61K 31/7048 | |||
| A61K 45/06 | |||
| A61P 3/04 | |||
| A61K 31/37 | |||
| A61K 31/375 | |||
| A61K 31/55 |
| (11) | Number of the document | 3096749 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15702348.2 |
| Date of filing the European patent application | 2015-01-21 | |
| (97) | Date of publication of the European application | 2016-11-30 |
| (45) | Date of publication and mention of the grant of the patent | 2019-05-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/012201 |
| Date | 2015-01-21 |
| (87) | Number | WO 2015/112568 |
| Date | 2015-07-30 |
| (30) | Number | Date | Country code |
| 201461931143 P | 2014-01-24 | US |
| (72) |
HOUGH, Douglas, R, US
STEVENS, Randall, M., US
|
| (73) |
Celgene Corporation,
86 Morris Avenue, Summit, NJ 07901,
US
|
| (54) | METHODS FOR THE TREATMENT OF OBESITY USING APREMILAST |
| METHODS FOR THE TREATMENT OF OBESITY USING APREMILAST |